Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.3 - $0.61 $19,958 - $40,582
-66,529 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.55 - $1.04 $36,590 - $69,190
66,529 New
66,529 $37,000
Q2 2021

Aug 16, 2021

SELL
$1.22 - $1.65 $19,679 - $26,616
-16,131 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$1.18 - $2.62 $22,391 - $49,717
-18,976 Reduced 54.05%
16,131 $25,000
Q3 2020

Nov 13, 2020

BUY
$1.7 - $6.41 $59,681 - $225,035
35,107 New
35,107 $71,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.